Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
4.290
-0.130 (-2.94%)
Mar 28, 2025, 4:00 PM EDT - Market closed
Camp4 Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Camp4 Therapeutics stock have an average target of 19.33, with a low estimate of 17 and a high estimate of 23. The average target predicts an increase of 350.58% from the current stock price of 4.29.
Analyst Consensus: Buy
* Price targets were last updated on Nov 5, 2024.
Analyst Ratings
The average analyst rating for Camp4 Therapeutics stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 4 | 4 | 4 | 4 | 4 |
| Hold | 2 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 0 |
| Total | 4 | 5 | 5 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Nov 5, 2024 |
| Leerink Partners | Leerink Partners | Buy Initiates $17 | Buy | Initiates | $17 | +296.27% | Nov 5, 2024 |
| JP Morgan | JP Morgan | Buy Initiates $23 | Buy | Initiates | $23 | +436.13% | Nov 5, 2024 |
| Piper Sandler | Piper Sandler | Buy Initiates $18 | Buy | Initiates | $18 | +319.58% | Nov 5, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $8.05 → $6.9 | Strong Sell | Maintains | $8.05 → $6.9 | +60.84% | Jan 11, 2024 |
Financial Forecast
Revenue This Year
21.29M
from 350.00K
Increased by 5,983.71%
Revenue Next Year
85.04M
from 21.29M
Increased by 299.39%
EPS This Year
-6.20
from -124.79
EPS Next Year
-2.95
from -6.20
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 87.2M | 349.7M | n/a |
| Avg | 21.3M | 85.0M | n/a |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 24,800.0% | 1,542.1% | - |
| Avg | 5,983.7% | 299.4% | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -3.92 | -2.76 | -2.37 |
| Avg | -6.20 | -2.95 | -2.41 |
| Low | -9.16 | -3.01 | -2.41 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.